As shown in Table 2 and Figure 3, CD4+CD25+CD127lowTregs in peripheral blood of patients with liver cancer in those≤ 49 years old (6.21±1.53%) were significantly higher than those in health subjects with the same age (3.30±1.45%; P<0.05). This evidence concerns the gene CD4 and liver cancer.